|

ZG005 Clinical Trials

3 actively recruiting trials

Pipeline

Phase 1/2: 3

Top Sponsors

  • Suzhou Zelgen Biopharmaceuticals Co.,Ltd3

Indications

  • Cancer3
  • Neuroendocrine Carcinoma2
  • Cervical Cancer1
  • Small Cell Lung Cancer1
  • Lung Cancer1

Other3 trials

Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma.
Phase 1/2
Study of ZG005 in Combination With Gecacitinib in Participants With Advanced Cervical Cancer
Phase 1/2
ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.